MaxQ AI is ushering in a new era of AI-augmented healthcare through medical diagnostic solutions that help empower physicians around the world to better prioritize and identify life-threatening conditions such as stroke and traumatic brain injury in acute care settings, which will save lives, improve the quality of care, and lower healthcare costs.
Our Mission
Our mission is to meaningfully reduce misdiagnosis and healthcare costs by making artificial intelligence intrinsic to the diagnostic process for time-sensitive and life-threatening conditions. When we’re successful, we’ll have elevated the global standard of acute medical care by providing universal future access to an expert-level diagnosis, prognosis, and therapeutic pathway through a comprehensive, seamless, secure, and trusted patient-level platform.
Our Focus
We are focused on building applications to enable doctors to reach faster, more accurate decisions when diagnosing stroke, traumatic brain injury, and other life-threatening conditions; and this is only the beginning. A new era is here. MaxQ AI is ushering in empowered care, the partnership between AI and the skilled caregiver to bring expert care to every patient.
Our Technology
Our products are based on artificial intelligence, deep learning, machine vision, and world-class clinical partners. We have developed software that uses artificial intelligence to interpret medical images such as non-contrast head computed tomography (CT) scans and surrounding patient data, for use in acute care settings. AI solutions are well-suited to help acute care physicians who are under extreme pressure to make quick and accurate decisions while treating a large number of patients.
Delivering A New Class Of Medial Diagnostic Artificial Intelligence, Striving To:
Enhance escalation and intervention confidence
Improve the quality of care, and lower healthcare costs
Deployed through major CT, AI ecosystem, and PACS channel partners
Greatly increase ICH detection and reduce missed ICHs through near real-time triage, annotation, and notification of absence of suspected ICH
Provide the right care readied faster, improving quality to potentially avoid poor patient outcomes and to potentially decrease costs and liability
Every Patient Deserves Equal Access
To Expert Care
THE OPPORTUNITY - MISDIAGNOSIS
Johns Hopkins investigators have estimated that medical errors are the #3 cause of death in the U.S.4
The overall misdiagnosis rate in healthcare is estimated at 30 percent, and it can be as high as 50 percent in certain situations.13
This means that roughly 1 in 3, and often 1 in 2, patients may be misdiagnosed.5
To compound this issue further, the Association of American Medical Colleges recently predicted the nationwide shortage of providers will reach up to 121,000 physicians by 2032.14
Stroke And Traumatic Brain Injury
Every minute counts to ensure effective treatment and address the massive social and economic implications of brain damage.
The unfortunate reality is the sheer volume of traumatic brain injury and stroke cases admitted annually to an ED, whether it be a small or large facility, is not only growing but is also a source of diagnostic error.
MaxQ AI RSNA 2019 Symposium
Highlights of "AI: Delivering on the Promise"
Video highlights of MaxQ AI’s RSNA 2019 Symposium entitled “AI: Delivering on the Promise”. This great #RSNA19 event, which was MaxQ AI’s second annual symposium, featured discussion, presentations and audience Q&A hosted and moderated by our CEO Gene Saragnese with speakers Dr. Ajay Choudhri, Chairman and Medical Director, Department of Radiology of Capital Health; Kenny Breal, Vice President of Clinical Operations, Infirmary Health System; and MaxQ AI’s CTO Tom Neufelder.
Channel Partners / Market Approach
More About ACCIPIO®
MaxQ’s AI’s ACCIPIO® ICH and Stroke Platform with INSIGHT™ integrates into a comprehensive, seamless, and secure workflow to augment acute care teams with deep clinical insight and actionable data in minutes. It will support the Radiology Department, Emergency Room, Neuroradiology and the Stroke teams. The Accipio Ix™ platform provides tools for automatic identification/detection, notification, acceleration, and prioritization of suspected ICH.
TRUSTED RESULTS
Provides highly accurate auto-processing of the DICOM adult non-contrast head CT images with suspected ICH using artificial intelligence for prioritization and triage of intracranial hemorrhage.
POWERFUL SIMPLICITY
Auto-returns rapid case-level summary report of a suspected intracranial hemorrhage to any DICOM compliant CT terminal or PACS worklist, informing if a suspected hemorrhage has been detected.
ABSOLUTE ZERO™
Zero clicks to ACCIPIO® results. Zero need to leave workflow. Zero stored PHI. Zero change to original series. No onsite IT integration required. Seamless from the Start™.
RIGOROUSLY TESTED
Class II FDA Cleared medical device. CE Approved. ISO 13485 certified manufacturer. GDPR compliant. Supports HIPAA compliance. ISO 27001 Information Management Security certified.
FLEXIBLE DEPLOYMENT, SPAN™
Maximum flexibility, rapidly deployed on major OEM CT and PACS, on-premises, and cloud-capable design. Able to grow with your CT and PACS.
Testimonials
At MaxQ AI, we are dedicated to revolutionizing the acute care setting with innovative ai solutions. our ACCIPIO® platform is geared toward improving treatment for head trauma and stroke care patients, while also streamlining facility workflow and empowering healthcare professionals. read what customers are saying about us and see why we’re inspired every day to do what we do.
Key Takeaways
RISK
THE OPPORTUNITY
Today, there is immense pressure on the healthcare industry. With fewer resources, a shortage of healthcare providers, and more images to read than ever before, solutions are crucial.
At MaxQ AI, our mission is to meaningfully reduce misdiagnosis and healthcare costs by making artificial intelligence intrinsic to the diagnostic process for time-sensitive and life-threatening conditions.
We are transforming healthcare by empowering physicians to provide “smarter care” with artificial intelligence (AI) clinical insights.
AI SOLUTIONS
AI EXPERTISE
MaxQ AI is at the cutting-edge of innovative Medical Diagnostic Artificial Intelligence. Our team of deep learning and machine vision experts develop innovative software that uses AI to interpret medical images and surrounding patient data.
We aspire to make a meaningful impact on stroke, head trauma, and traumatic brain injury (TBI) treatment across the world driven by the question “what is the cost of a missed intracranial hemorrhage (ICH)?”.
EXPERTISE
TRUSTED PARTNER
Deployed through Major CT, AI ecosystem, and PACS channel partners; completely integrated, supported, and serviced from companies you trust.
Our partners distribute our on-premise and cloud-capable solution globally and include GE Healthcare (CT and PACS), IBM Watson, Philips (CT and PACS), FujiFilm, TeraRecon, Nuance, Arterys, Blackford, and Samsung Neurologica.
REGULATIONS
We prioritize absolute rigor in all certifications, systems, security, and compliance to ensure the company behind the platforms leads by example.
- FDA Breakthrough Status, Class II FDA Cleared
- ISO13485, FDA QSR, ISO14971, IEC62304, IEC62366 Standards Certified.
- Supports HIPAA Compliance. GDPR Compliant.
- ISO 27001 Information Management Security System Certification.
- Data truthing by board-certified physicians.
- FDA Pre-Certification Member.